Results 71 to 80 of about 8,500 (184)

An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages.

open access: yesPLoS Neglected Tropical Diseases, 2012
Leishmaniasis is a tropical disease threatening 350 million people from endemic regions. The available drugs for treatment are inadequate, with limitations such as serious side effects, parasite resistance or high cost. Driven by this need for new drugs,
Jair L Siqueira-Neto   +9 more
doaj   +1 more source

Revealing Annexin A2 and ARF-6 enrollment during Trypanosoma cruzi extracellular amastigote-host cell interaction

open access: yesParasites & Vectors, 2015
Background Invasion of host cells by Trypanosoma cruzi extracellular amastigotes is host actin polymerization-dependent. However, the role of proteins related to actin dynamics during invasion by amastigotes remains to be investigated.
Thaise Lara Teixeira   +3 more
doaj   +1 more source

Investigation and Comparison of Leishmania major Promastigote and Amastigote Protein Content by Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis

open access: yesپزشکی بالینی ابن سینا, 2013
Introduction & Objective: Leishmania is a protozoan of the trypanosomatidae family. This protozoan has two stages in its life cycle, promastigote form in sand flies and amastigote form in macrophage of mammalian hosts.
Simindokht Soleimanifard   +2 more
doaj  

Detection and counting of Leishmania intracellular parasites in microscopy images

open access: yesFrontiers in Medical Technology
ProblemLeishmaniasis is a disease caused by protozoan parasites of the genus Leishmania and has a high prevalence and impact on global health. Currently, the available drugs for its treatment have drawbacks, such as high toxicity, resistance of the ...
Lariza María de la Caridad Portuondo-Mallet   +4 more
doaj   +1 more source

CUTANEOUS LEISHMANIASIS: AN EXPERIENCE AT UMDC

open access: yesJournal of University Medical & Dental College, 2014
: Leishmaniasis is caused by single-cell parasites of the genus Leishmania. More than 10 different Leishmania species can cause human diseases. The two main clinical manifestations of leishmaniasis are:  Visceral leishmaniasis  Cutaneous leishmaniasis ...
Tabinda Roheen   +2 more
doaj  

Biological properties and in silico studies of thiazolopyrimidine derivatives active against visceral and cutaneous Leishmania spp. amastigote forms

open access: yesEuropean Journal of Medicinal Chemistry Reports
Visceral leishmaniasis, the most severe form of the disease, is caused by L. donovani and L. infantum parasites; cutaneous leishmaniasis is the most common endemic form of leishmaniasis and mainly caused by L. tropica and L. major.
Gulsah Bayraktar   +7 more
doaj   +1 more source

Amastigotes de Leishmania spp.

open access: yesRevista Experiencia en Medicina del Hospital Regional Lambayeque, 2020
Cesar Alberto Cabrejos Montalvo   +1 more
openaire   +2 more sources

Role of Leishmania (Leishmania) amazonensis amastigote glycosphingolipids in macrophage infectivity

open access: yesBrazilian Journal of Medical and Biological Research, 2007
The role of glycosphingolipids (GSLs) present in amastigote forms of Leishmania (Leishmania) amazonensis during infection of macrophages was analyzed, with particular emphasis on GSLs presenting the terminal Galpß1-3Galpa disaccharide.
A.K. Tanaka   +3 more
doaj  

Visceral leishmaniasis: amastigotes in the bone marrow

open access: yesHematology, Transfusion and Cell Therapy, 2019
Noronha, Thiago Rodrigo de   +1 more
openaire   +2 more sources

Amastigotes forms of Trypanosoma cruzi detected in a renal allograft

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 1997
Trypanosoma cruzi, the causative agent of Chagas?disease assumes two distinct forms in vertebrate hosts: circulating trypomastigote and tissular amastigote.
CARVALHO Maria Fernanda C.   +2 more
doaj  

Home - About - Disclaimer - Privacy